Abstract
Benzazolo[3,2-a]quinolium salts (BQS) are cationic quaternary alkaloids with similar structure to the anticancer agent ellipticine. This study describes the synthesis and screen, at the experimental concentration of 10 mM, utilizing the 60 cell line anti-cancer screening of two BQS, namely, 7-benzyl-3- aminobenzimidazo[3,2-a]quinolinium chloride (ABQ-48: NSC D-763307) and the corresponding 7-benzyl-3- nitrobenzimidazo[3,2-a]quinolinium chloride (NBQ 48: NSC D-763303). Compound ABQ-48: NSC D-763307 was also screened in the 5-dose NCI panel. These compounds differ in the presence of an amino or nitro substituent at the 3- position in ring A. The data show that ABQ 48 with electron donating amino group at position 3 in ring A is highly effective in the growth inhibition in several cancer cell lines. However, its analog NBQ 48 which has an electron withdrawing nitrogen group at this position has negligible effect in most of the cell lines. In particular, ABQ 48 shows >90% growth inhibition in KM12, U251 & SK-MEL-5; and >70% growth inhibition in several cell lines. As per the NCI’s screening criteria ABQ 48 showed better than 60% growth inhibition in at least eight tumor cell lines, and thus, selected for the five dose response study. It is therefore concluded that the biological activity of these compounds is greatly affected by their electron donating properties. Additionally, this work describes the complete proton and carbon-13 chemical shifts assignments using 1D and 2D nuclear magnetic resonance techniques.
Keywords: Cancer, quinolinium salts, synthesis.
Current Bioactive Compounds
Title:Synthesis of and Biological Study of 7-Benzyl-3-aminobenzimidazo[3,2- a]quinolinium Chloride (ABQ-48: NSC D-763307) and 7-benzyl-3- nitrobenzimidazo[3,2-a]quinolinium Chloride (NBQ 48: NSC D-763303)
Volume: 10 Issue: 4
Author(s): Osvaldo Cox, Christian Velez, Vineet Kumar, Sanjay V. Malhotra, Luis A. Rivera, Wigberto J. Hernandez, Jose R. Martinez, Marisol Cordero and Beatriz Zayas
Affiliation:
Keywords: Cancer, quinolinium salts, synthesis.
Abstract: Benzazolo[3,2-a]quinolium salts (BQS) are cationic quaternary alkaloids with similar structure to the anticancer agent ellipticine. This study describes the synthesis and screen, at the experimental concentration of 10 mM, utilizing the 60 cell line anti-cancer screening of two BQS, namely, 7-benzyl-3- aminobenzimidazo[3,2-a]quinolinium chloride (ABQ-48: NSC D-763307) and the corresponding 7-benzyl-3- nitrobenzimidazo[3,2-a]quinolinium chloride (NBQ 48: NSC D-763303). Compound ABQ-48: NSC D-763307 was also screened in the 5-dose NCI panel. These compounds differ in the presence of an amino or nitro substituent at the 3- position in ring A. The data show that ABQ 48 with electron donating amino group at position 3 in ring A is highly effective in the growth inhibition in several cancer cell lines. However, its analog NBQ 48 which has an electron withdrawing nitrogen group at this position has negligible effect in most of the cell lines. In particular, ABQ 48 shows >90% growth inhibition in KM12, U251 & SK-MEL-5; and >70% growth inhibition in several cell lines. As per the NCI’s screening criteria ABQ 48 showed better than 60% growth inhibition in at least eight tumor cell lines, and thus, selected for the five dose response study. It is therefore concluded that the biological activity of these compounds is greatly affected by their electron donating properties. Additionally, this work describes the complete proton and carbon-13 chemical shifts assignments using 1D and 2D nuclear magnetic resonance techniques.
Export Options
About this article
Cite this article as:
Cox Osvaldo, Velez Christian, Kumar Vineet, V. Malhotra Sanjay, A. Rivera Luis, J. Hernandez Wigberto, R. Martinez Jose, Cordero Marisol and Zayas Beatriz, Synthesis of and Biological Study of 7-Benzyl-3-aminobenzimidazo[3,2- a]quinolinium Chloride (ABQ-48: NSC D-763307) and 7-benzyl-3- nitrobenzimidazo[3,2-a]quinolinium Chloride (NBQ 48: NSC D-763303), Current Bioactive Compounds 2014; 10 (4) . https://dx.doi.org/10.2174/1573407210666141126204355
DOI https://dx.doi.org/10.2174/1573407210666141126204355 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Genistein: A Phytoestrogen with Multifaceted Therapeutic Properties
Mini-Reviews in Medicinal Chemistry A Review on Lung Cancer Diagnosis Using Data Mining Algorithms
Current Medical Imaging Compound Ranking Based on a New Mathematical Measure of Effectiveness Using Time Course Data from Cell-Based Assays
Combinatorial Chemistry & High Throughput Screening Doxorubicin Sensitizes the Non-Small Cell Lung Cancer Cells to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Mediated (TRAIL) Apoptosis In Vitro but not In Vivo
Letters in Drug Design & Discovery Transactivation of EGFR by G Protein-Coupled Receptor in the Pathophysiology of Intimal Hyperplasia
Current Vascular Pharmacology miRNA and Proteomic Dysregulation in Non-Small Cell Lung Cancer in Response to Cigarette Smoke
MicroRNA Patenting of Nanopharmaceuticals in Drug Delivery: No Small Issue
Recent Patents on Drug Delivery & Formulation Endoscopic Microscopy Using Optical Coherence Tomography
Current Medical Imaging Cytokine/Antibody Complexes: An Emerging Class of Immunostimulants
Current Pharmaceutical Design Erlotinib: A Targeted Anticancer Drug
Current Cancer Therapy Reviews TNF-α Induction by Nickel Compounds is Specific Through ERKs/AP-1- Dependent Pathway in Human Bronchial Epithelial Cells
Current Cancer Drug Targets Targeted Delivery of Tumor Suppressor microRNA-1 by Transferrin- Conjugated Lipopolyplex Nanoparticles to Patient-Derived Glioblastoma Stem Cells
Current Pharmaceutical Biotechnology Macromolecular Drug Targets in Cancer Treatment and Thiosemicarbazides as Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Reactive Oxygen Species in Cancer Biology and Anticancer Therapy
Current Medicinal Chemistry Research Advances of Endostatin and its Short Internal Fragments
Current Protein & Peptide Science Muscarinic Acetylcholine Receptor-Interacting Proteins (mAChRIPs): Targeting the Receptorsome
Current Drug Targets A Brief Review of the Essential Role of Nanovehicles for Improving the Therapeutic Efficacy of Pharmacological Agents Against Tumours
Current Drug Delivery Functionalized Silver Nanoparticles for Sensing, Molecular Imaging and Therapeutic Applications
Current Nanomedicine Prolyl-Specific Peptidases and Their Inhibitors in Biological Processes
Current Chemical Biology Perspectives in Biomolecular Therapeutic Intervention in Cancer: From the Early to the New Strategies With Type I Interferons
Current Medicinal Chemistry